AMPLIA THERAPEUTICS LIMITED
Who is AMPLIA THERAPEUTICS LIMITED?
Amplia Therapeutics Limited (ASX: ATX; OTCQB: INNMF), a pharmaceutical company based in Melbourne, Australia, focuses on development of focal adhesion kinase (FAK) inhibitors for the treatment of cancer and chronic fibrotic diseases. The company's lead product is narmafotinib (AMP945), a best-in-cla...See more
Industry & Specialities
Pharmaceuticals
Manufacturing
Countries of Operation
Australia
Headquarters:
Australia
Company Type:
MNC / Large Enterprise
Company size:
1-10 Employees
Year Founded:
2016 (10 years)
Address:
90 WILLIAM ST; LEVEL 5; MELBOURNE, VICTORIA 3000, AU
Employees by Department
Key Decision Makers
Mark Devlin
Scientific Advisor
Charlotte Mulder
Director Early Clinical Development
Terrie Anne C
Director Translational Science
Employees by Seniority
C-level
1employees
Senior
1employees
Non-managers
2employees
Financials
LOW
spending power
Funding Status
Publicly listed on stock exchange
Associated Legal Entities
0 entities
Discover More Companies
Featured Lists
- SMEs in Singapore
- MNCs / Large Enterprises in Singapore
Frequently Asked Questions (FAQ)
- How long has AMPLIA THERAPEUTICS LIMITED been operating for?
- What is the funding status of AMPLIA THERAPEUTICS LIMITED?
- Where is AMPLIA THERAPEUTICS LIMITED's headquarter?
- What AMPLIA THERAPEUTICS LIMITED's spending power?
- Does AMPLIA THERAPEUTICS LIMITED have a presence in the domain it operates in?